Portola Pharmaceutical Inc. Company Profile

09:53 EST 12th December 2018 | BioPortfolio

Portola Pharmaceutical Inc. is a private biopahrmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease


270 East Grand Avenue, Suite 22
South San Fransisco
United States of America


Phone: 650-246-7376
Email: careers@PORTOLA.COM

News Articles [248 Associated News Articles listed on BioPortfolio]

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Portola Pharmaceuticals (NASDAQ: PTLA) CEO Bill Lis is retiring from the South San Francisco, CA, drug developer. Lis will also retire from Portola’s board of directors. The company said Lis will re...

Portola Pharma Picks Scott Garland to Succeed Bill Lis as CEO

Scott Garland will become president and CEO of Portola Pharmaceuticals (NASDAQ: PTLA) effective Oct. 8. Garland will also join the South San Francisco, CA, company’s board of directors. Garland is c...

FDA grants orphan status to Portola's lymphoma drug

Portola Pharmaceuticals' cerdulatinib, being developed as a treatment for patients with peripheral T-cell lymphoma, was given -More- 

Portola inches closer to large-scale Andexxa production

Roll-out of the anticoagulant antidote has so far been limited to only a few dozen centers as Portola awaits approval of a second-gen production process.

Portola Pharmaceuticals’ CEO to Step Down

Portola Pharmaceuticals’ chief executive officer, William Lis, plans to retire as both chief executive and board member.

Garland Takes Helm Of Portola At A Crucial Time

Portola touts exec's commercial management experience with Genentech success stories Avastin and Tarceva.    

#jobs #lifescience Compliance Manager – Snr Pharmaceutical/Biotech Industry

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Compliance Manager – Snr Pharmaceutical/Biotech Industry .CA-South San ...

Small-Cap Snapshot: The Brink’s Company shares surge following $50 million stock buyback

Newmark Group Inc (NASDAQ:NMRK), The Brink’s Company (NYSE:BCO), Portola Pharmaceuticals Inc (NASDAQ:PTLA), Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN). 

PubMed Articles [508 Associated PubMed Articles listed on BioPortfolio]

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

Applications of proteomics in pharmaceutical research and development.

The significance of proteomics in the pharmaceutical industry has increased since overcoming initial difficulties. This review discusses recent proteomics publications from pharmaceutical companies to...

Solid-state insight into the action of a pharmaceutical solvate: structural, thermal and dissolution analysis of indinavir sulfate ethanolate.

The crystal structure of indinavir sulfate, a pharmaceutical administered as an ethanol solvate, is presented, revealing a unique channel/ionic solvate structure to be characteristic of the compound. ...

Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations.

A pharmaceutical suspension is a semi-liquid dosage form suitable for patients being unable to swallow solid medicines such as tablets and capsules. A vehicle used for the preparation of pharmaceutica...

Clinical Trials [332 Associated Clinical Trials listed on BioPortfolio]

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [1048 Associated Companies listed on BioPortfolio]

Portola Pharmaceutical Inc.

Portola Pharmaceutical Inc. is a private biopahrmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular...

Merck and Portola Pharmaceuticals

Portola Pharmaceuticals discovers and develops innovative therapeutics based on targets with established proof of concept that are designed to provide significant advances over cu...

Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascula...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Pharmaceutical Online

Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...

More Information about "Portola Pharmaceutical Inc." on BioPortfolio

We have published hundreds of Portola Pharmaceutical Inc. news stories on BioPortfolio along with dozens of Portola Pharmaceutical Inc. Clinical Trials and PubMed Articles about Portola Pharmaceutical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Portola Pharmaceutical Inc. Companies in our database. You can also find out about relevant Portola Pharmaceutical Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Corporate Database Quicklinks

Searches Linking to this Company Record